• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血预处理作用于再灌注阶段。

Ischemic preconditioning targets the reperfusion phase.

作者信息

Hausenloy Derek J, Wynne Abigail M, Yellon Derek M

机构信息

The Hatter Cardiovascular Institute, University College London Hospital and Medical School, 67 Chenies Mews, London, WC1E 6HX, UK.

出版信息

Basic Res Cardiol. 2007 Sep;102(5):445-52. doi: 10.1007/s00395-007-0656-1. Epub 2007 May 29.

DOI:10.1007/s00395-007-0656-1
PMID:17530316
Abstract

Emerging studies suggest that signaling during the myocardial reperfusion phase contributes to ischemic preconditioning (IPC). Whether the activation of PKC, the opening of the mKATP channel, redox signaling and transient acidosis specifically at the time of myocardial reperfusion are required to mediate IPC-induced protection is not known. Langendorff-perfused rat hearts were subjected to 35 min ischemia followed by 120 min reperfusion at the end of which infarct size was determined by tetrazolium staining. Control and IPC-treated hearts were randomized to receive for the first 15 min of reperfusion: (1) DMSO (0.02%) vehicle control; (2) chelerythrine (10 micromol/l), a PKC antagonist; (3) 5 hydroxydecanoate (5- HD,100 micromol/l), a mKATP channel blocker; (4) N-mercaptopropionylglycine (MPG,1 mmol/l), a reactive oxygen species scavenger; (5) NaHCO3 (pH 7.6), to counteract any acidosis. Interestingly, all four agents given at the time of myocardial reperfusion abolished the infarct reduction elicited by IPC (N>6/group): (1) DMSO at reperfusion: 49.3+/-3.6% in control versus 21.0+/-3.6% with IPC:P<0.05; (2) chelerythrine at reperfusion: 57.1+/-2.5% in control versus 60.1+/-3.3% with IPC:P=NS; (3) 5-HD at reperfusion: 53.4+/-6.5 % in control versus 42.6+/-4.4% with IPC:P=NS; (4) MPG at reperfusion: 55.3+/-4.6% in control versus 43.9+/-5.2% with IPC:P=NS; (5) NaHCO3 at reperfusion 53.4+/-2.5% in control versus 59.0+/-3.3% with IPC:P=NS. In conclusion, we report for the first time that PKC activation, mKATP channel opening, redox signaling and a low pH at the time of myocardial reperfusion are required to mediate the cardioprotection elicited by ischemic preconditioning.

摘要

新出现的研究表明,心肌再灌注阶段的信号传导有助于缺血预处理(IPC)。目前尚不清楚心肌再灌注时PKC的激活、mKATP通道的开放、氧化还原信号传导和短暂性酸中毒是否是介导IPC诱导的保护作用所必需的。采用Langendorff灌注的大鼠心脏,先进行35分钟的缺血,然后进行120分钟的再灌注,再灌注结束时通过四氮唑染色确定梗死面积。将对照和IPC处理的心脏随机分组,在再灌注的前15分钟给予:(1)二甲基亚砜(DMSO,0.02%)作为溶剂对照;(2)白屈菜红碱(10微摩尔/升),一种PKC拮抗剂;(3)5-羟基癸酸(5-HD,100微摩尔/升),一种mKATP通道阻滞剂;(4)N-巯基丙酰甘氨酸(MPG,1毫摩尔/升),一种活性氧清除剂;(5)碳酸氢钠(pH 7.6),以抵消任何酸中毒。有趣的是,在心肌再灌注时给予的所有四种药物都消除了IPC引起的梗死面积减小(每组N>6):(1)再灌注时给予DMSO:对照组为49.3±3.6%,IPC组为21.0±3.6%:P<0.05;(2)再灌注时给予白屈菜红碱:对照组为57.1±2.5%,IPC组为60.1±3.3%:P=无显著性差异;(3)再灌注时给予5-HD:对照组为53.4±6.5%,IPC组为42.6±4.4%:P=无显著性差异;(4)再灌注时给予MPG:对照组为55.3±4.6%,IPC组为43.9±5.2%:P=无显著性差异;(5)再灌注时给予碳酸氢钠:对照组为53.4±2.5%,IPC组为59.0±3.3%:P=无显著性差异。总之,我们首次报道心肌再灌注时PKC激活、mKATP通道开放、氧化还原信号传导和低pH值是介导缺血预处理引起的心脏保护作用所必需的。

相似文献

1
Ischemic preconditioning targets the reperfusion phase.缺血预处理作用于再灌注阶段。
Basic Res Cardiol. 2007 Sep;102(5):445-52. doi: 10.1007/s00395-007-0656-1. Epub 2007 May 29.
2
Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.短暂的线粒体通透性转换孔开放介导预处理诱导的保护作用。
Circulation. 2004 Apr 13;109(14):1714-7. doi: 10.1161/01.CIR.0000126294.81407.7D. Epub 2004 Apr 5.
3
Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.缺血预处理大鼠心脏释放的体液因子的心脏保护特性。
J Cardiovasc Pharmacol. 2007 Apr;49(4):214-20. doi: 10.1097/FJC.0b013e3180325ad9.
4
Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation.后适应诱导的心脏保护需要通过氧化还原敏感机制、线粒体ATP敏感性钾通道和蛋白激酶C激活进行信号传导。
Basic Res Cardiol. 2006 Mar;101(2):180-9. doi: 10.1007/s00395-006-0584-5. Epub 2006 Feb 6.
5
Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts.线粒体ATP敏感性钾通道开放在缺血预处理大鼠心脏的初次缺血期间及心肌再灌注后具有重要作用。
J Mol Cell Cardiol. 2001 Apr;33(4):831-4. doi: 10.1006/jmcc.2001.1350.
6
The ischemia-selective KATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart.缺血选择性ATP敏感性钾通道拮抗剂5-羟基癸酸可阻断大鼠心脏的缺血预处理。
J Mol Cell Cardiol. 1997 Mar;29(3):1055-60. doi: 10.1006/jmcc.1996.0358.
7
Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.缺血预处理与17β-雌二醇介导的心肌细胞KATP通道激活之间的相似性,这种激活在完整兔心脏缺血/再灌注期间产生心脏保护和抗心律失常作用。
J Cardiovasc Pharmacol. 2006 Feb;47(2):277-86. doi: 10.1097/01.fjc.0000202563.54043.d6.
8
Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).用肿瘤坏死因子-α进行药理预处理可在再灌注时激活信号转导和转录激活因子-3,且不涉及经典的促存活激酶(Akt和细胞外信号调节激酶)。
Circulation. 2005 Dec 20;112(25):3911-8. doi: 10.1161/CIRCULATIONAHA.105.581058. Epub 2005 Dec 12.
9
The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction.C反应蛋白在大鼠心肌梗死模型的缺血/再灌注损伤及预处理中的作用
Life Sci. 2004 Jul 9;75(8):901-10. doi: 10.1016/j.lfs.2003.12.029.
10
Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.PKC-δ 的可能参与导致高同型半胱氨酸血症大鼠心脏缺血预处理的心脏保护作用减弱。
Biomed Pharmacother. 2010 Mar;64(3):195-202. doi: 10.1016/j.biopha.2009.04.030. Epub 2009 Oct 17.

引用本文的文献

1
Management of ROS and Regulatory Cell Death in Myocardial Ischemia-Reperfusion Injury.心肌缺血再灌注损伤中活性氧的管理与调节性细胞死亡
Mol Biotechnol. 2025 May;67(5):1765-1783. doi: 10.1007/s12033-024-01173-y. Epub 2024 Jun 9.
2
Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning.远隔缺血预处理机制中神经与体液途径的相互依存关系。
Basic Res Cardiol. 2016 Jul;111(4):50. doi: 10.1007/s00395-016-0568-z. Epub 2016 Jun 23.
3
Molecular Characterization of Reactive Oxygen Species in Myocardial Ischemia-Reperfusion Injury.
心肌缺血再灌注损伤中活性氧的分子特征
Biomed Res Int. 2015;2015:864946. doi: 10.1155/2015/864946. Epub 2015 Oct 5.
4
Positive oxidative stress in aging and aging-related disease tolerance.衰老及衰老相关疾病耐受性中的正向氧化应激。
Redox Biol. 2014;2:165-9. doi: 10.1016/j.redox.2014.01.002. Epub 2014 Jan 9.
5
Redox signalling and cardioprotection: translatability and mechanism.氧化还原信号传导与心脏保护:可转化性与机制
Br J Pharmacol. 2015 Apr;172(8):1974-95. doi: 10.1111/bph.12975. Epub 2015 Jan 12.
6
Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.衰竭心脏中的线粒体氧化代谢与解偶联蛋白
Heart Fail Rev. 2015 Mar;20(2):227-49. doi: 10.1007/s10741-014-9457-4.
7
Concentration-dependent wrestling between detrimental and protective effects of H2O2 during myocardial ischemia/reperfusion.心肌缺血/再灌注期间,过氧化氢的有害作用与保护作用之间存在浓度依赖性的相互作用。
Cell Death Dis. 2014 Jun 19;5(6):e1297. doi: 10.1038/cddis.2014.267.
8
The polymorphic and contradictory aspects of intermittent hypoxia.间歇性低氧的多态性和矛盾性。
Am J Physiol Lung Cell Mol Physiol. 2014 Jul 15;307(2):L129-40. doi: 10.1152/ajplung.00089.2014. Epub 2014 May 16.
9
Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery.血管紧张素II与缺血预处理协同作用可改善线粒体功能,同时对心室缺血后恢复呈现相加效应。
J Cardiovasc Pharmacol. 2014 Aug;64(2):172-9. doi: 10.1097/FJC.0000000000000103.
10
Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.三重疗法大大增加了原位大鼠心脏缺血/再灌注期间的心肌挽救。
Cardiovasc Drugs Ther. 2013 Oct;27(5):403-12. doi: 10.1007/s10557-013-6474-9.